Injectable Drug Delivery Market is Expected to Reach $39.6 billion by 2023.

According to the new market research report by IndustryARC titled “Injectable Drug Delivery Market By Devices, Therapeutics & Formulations [Self-Injection Devices (Pen, Needle Free &Auto Injectors), Auto-Immune Diseases, Diabetes, Oncology, Hormonal Disorders, Liposomes, Microspheres, Nanoparticles, Polymeric Micelles] - Forecast (2018 - 2023)”, the market is driven by the growth of the Biologics during the forecast period.

North America dominates the Injectable Drug Delivery Market

North America holds a major share in the Injectable Drug Delivery Market. In the US, chronic disease like heart diseases, diabetes, cancer, stroke, chronic obstructive pulmonary disorder, etc are prevalent. These factors drive the demand for the formulations. The number of Americans suffering from diabetes could triple by 2050.

Favourable business environment, government support, and surge of biologics propel the demand for the injectable drug delivery devices in North America.

Selected Analysis in the full Report:

Self-injection devices include auto injectors, pen injectors, and needle free injectors. These devices are used for self-administration of medication by the patients. They are used for administration of injectable drug modules such as insulin, interferon, follicle stimulating hormone, and human growth hormone. Insulin dependent diabetes is the main therapeutic area for application of self-injection devices.

The self-injection devices segment is expected to have a healthy growth rate due to factors such as growth of Biotechnology and pharmaceuticals based research. Growing incidences of diabetes is also another factor for the growth of self-injection devices.

Talk to one of our sales representative about the full report by providing your details in the link below:

https://industryarc.com/support.php?id=1255

Excerpts on Market Growth Factors

• Growing diabetic population has been increasing across several regions. Diabetes can be treated by glucose monitors, insulin pumps. Usage of syringes is also used for treatment purposes.

• Growing prevalence of multiple sclerosis is the main factor that enhances the demand for injectable. For treating multiple sclerosis, self-injection devices are marketed.

• Injectable drug delivery is simple to deliver due to the large molecular size of Biologics and its high effectiveness. This factor drives the demand for drug delivery devices.

Key players of the Injectable Drug Delivery Market

Becton Dickinson & Co, Baxter International, Terumo Corporation, Schott AG dominate the Injectable Drug Delivery Market. The other players include West Pharmaceutical Services, Unilife Corporation, Gerresheimer AG, and B Braun Melsungen AG.

Becton Dickinson & Co is a company with advanced medical technology engaged in development, manufacture, and sale of devices, instrument systems, diagnostic products, etc. Baxter International manufactures medical devices, pharmaceuticals, and Biotechnology products. Schott AG operates in the business segments such as solar power, electronic packaging, fiber optics, pharmaceutical systems, home tech, and flat glass.

Unilife Corporation which is headquartered in Pennsylvania focuses on the manufacture and supply of injectable drug delivery systems.

Companies Citied / Interviewed

1. ALKERMES, INC.
2. ANTARES PHARMA, INC.
3. BAXTER INTERNATIONAL, INC.
4. BECTON, DICKINSON AND COMPANY
5. BESPAK EUROPE, LTD
6. CROSSJECT SA
7. ELCAM MEDICAL
8. ELI LILLY AND COMPANY
9. GERRESHEIMER AG
10. HASELMEIER GMBH
11. INJEX PHARMA GMBH
12. NOVO NORDISK A/S
13. OWEN MUMFORD, LTD.
14. SANOFI
15. Company 15
16. Company 16+

Related Report:

1. Connected Injectable Drug Delivery Devices Market

2. Self-Testing and Self Injectable Devices Market

Injectable Drug Delivery Market is segmented as below

A. Injectable Drug Delivery Market By Drug Formulations

1. Conventional Drug Delivery Formulations

1.1. Injectable Drug Delivery Formulation Solutions

1.2. Reconstituted Drug Delivery Formulation Solutions

2. Novel Drug Delivery Formulation Solutions

2.1. Liposomal Systems

2.2. Microspheres

2.3. Nanoparticles

2.4. Polymeric Micelles

2.5. Others

B. Injectable Drug Delivery Market By Therapeutic areas

1. Auto-Immune Diseases

1.1. Multiple Sclerosis

1.2. Rheumatoid Arthritis

1.3. Crohn's Diseases

1.4. Psoriasis

1.5. Others

2. Hormonal Disorders

2.1. Diabetes

2.2. Anemia

2.3. Reproductive Health Diseases

2.4. Osteoporosis

2.5. Growth Hormone Deficiency

2.6. Antithrombotic Therapy

3. Orphan Or Rare Diseases

4. Oncology

5. Others

5.1. Pain Management

5.2. Hepatitis C

5.3. Allergies

5.4. Aesthetic Treatment

C. Injectable Drug Delivery Market by Geography (covers 9+ countries)

E. Injectable Drug Deliver Market Entropy

Media Contact:

Mr. Venkat Reddy

Sales Manager

Email : sales@industryarc.com

Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences &Healthcare.